Summary ofresults
The data presented suggest that any increased trabecular bone loss seen in patients receiving luteinising hormone releasing hormone agonist treatment might be a factor in determining both the duration of treatment and the timing of possible repeated courses in premenopausal women receiving sucb agonists for the treatment of benign gynaecological conditions.
We thank Hoechst-Roussel (United States) for supporting WHM and funding bone density studies and Dr P Magill (Hoechst-UK) for supplying Buserelin. We also thank Dr J Reeve (Clinical Research Centre, Northwick Park Hospital) and Dr R Evans (radiology department, Northwick Park Hospital) for their continued support and advice. Case report A 52 year old white homosexual man presented with a two month history of malaise and a painful lump in the right thigh. There was a history of syphilis and of acute allergic vasculitis, which had settled spontaneously. He denied any sexual contact for seven years. There was no history of drug abuse, trauma, or recent travel abroad.
On examination he was feverish (38°C). There was erythema overlying a mass in the right thigh measuring 6x4 cm. Physical examination showed nothing remarkable except an anal ulcer. Further investigation showed: haemoglobin 122 g/l, white cell count 5-2 x 10/1, Westergren erythrocyte sedimentation rate (ESR) 56 mm in first hour, and albumin 32 g/l. There was serological evidence of previous syphilitic infection. Enzyme linked immunosorbent assay (ELISA) for HIV antibodies was positive. Blood cultures on three occasions were sterile. Ultrasound scanning showed an intramuscular necrotic mass (figure), and an abscess was found at open biopsy. The pus was sterile, and histological examination of the abscess wall showed non-specific inflammation without evidence of malignancy. Fever persisted after the operation, intravenous gentamicin and flucloxacillin were given for 48 hours, and the abscess healed. Intercurrent oropharyngeal candidiasis responded to amphotericin. The patient has subsequently developed a progressive encephalopathy. 
Myocardial infarction due to amphetamine
We report on a patient with myocardial infarction probably resulting from self administration of intravenous amphetamine.
Case report
A 33 year old white building labourer was admitted with chest pain. He was a known drug addict, taking 500-750 mg of heroin intravenously each week and occasionally taking other substances. One hour before the onset ofhis pain he had injected himself with about 60 mg of amphetamine, having injected 40 mg of heroin several hours earlier. Two years previously he had been admitted with similar chest pain; at the time no history of drug abuse was elicited, but later he had admitted to taking amphetamine intravenously one hour before. He cleaned his needles in hot water and occasionally shared needles. He smoked about 20 cigarettes a day and drank alcohol occasionally. His mother had died of myocardial infarction at the age of 41.
On admission he was drowsy and in pain. There were no abnormal signs apart from venepuncture scars on his arms. Serial electrocardiograms showed the development of abnormal Q waves and typical ST-T segment changes due to an inferolateral myocardial infarct (figure). Peak serum enzyme concentrations were raised: aspartate aminotransferase 235 IU (normal 15-40 IU/1) and lactate dehydrogenase 708 IU/l (normal 115-235 IU/1). Blood glucose concentration measured at random was normal at 5-6 mmol/l. Results of serological tests for human immunodeficiency virus were negative. Hepatitis B surface antibody was present in low titre, but hepatitis B surface antigen and e antigens were absent. On his previous admission pericarditis had been diagnosed, but enzyme concentrations were not measured. Electrocardiograms at that time showed changes compatible with a non-Q wave anterolateral infarct.
He made an uneventful recovery from his presumed second infarct and had no withdrawal symptoms. On discharge from hospital seven days later he was not receiving any drugs. At follow up he denied smoking or taking drugs. Coronary arteriograms performed three months after the infarction were normal. A left ventricular angiogram was also normal apart from slightly diminished apical contraction. Blood lipid concentrations were normal, with a cholesterol concentration of 5-2 mmol/l.
Comment
Amphetamine is a sympathomimetic drug which acts by releasing noradrenaline from sympathetic nerve endings. Catecholamines can cause myocardial damage by increasing myocardial oxygen demand or by causing platelet aggregation. In animals pretreatment with antiplatelet drugs may prevent catecholamine induced myocardial necrosis.' Noradrenaline usually causes dilatation, but in some people it may cause coronary artery spasm.2 As far as we are aware acute myocardial ischaemia due to heroin has not been reported, although this drug is known to cause pulmonary oedema, arrhythmias, and hypoxia.
Congestive cardiomyopathy has been reported in a woman who used oral dextroamphetamine almost continuously for 12 years3 and in four men who regularly used intravenous propylhexedrine, an amphetamine analogue.4 In three of these cases coronary arteriograms were normal. There have been two reports of acute cardiomyopathy related to intravenous amphetamine abuse, and in both cases coronary arteriograms were normal.' 5
It is increasingly recognised that myocardial infarction may occur in patients with subsequently normal coronary arteriograms. The mechanism is uncertain, but lysis of thrombus and coronary artery spasm are common explanations.
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